Guide Complete Set of Residential Architectural Drawings PDF
Ym bio sciences inc. – product pipeline review – 2012
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
YM BioSciences Inc. – Product Pipeline Review – 2012
More about this report
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “YM BioSciences Inc. - Product
Pipeline Review - 2012” provides data on the YM BioSciences Inc.’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, YM BioSciences Inc.’s corporate website, SEC filings, investor
presentations and featured press releases, both from YM BioSciences Inc. and
industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- YM BioSciences Inc. - Brief YM BioSciences Inc. overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of YM BioSciences Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
2. Table of contents:
List of Tables 5
List of Figures 5
YM BioSciences Inc. Snapshot 6
YM BioSciences Inc. Overview 6
Key Information 6
Key Facts 6
YM BioSciences Inc. – Research and Development Overview 7
Key Therapeutic Areas 7
YM BioSciences Inc. – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Pipeline Products – Combination Treatment Modalities 12
YM BioSciences Inc. – Pipeline Products Glance 13
YM BioSciences Inc. – Late Stage Pipeline 13
Phase III Products/Combination Treatment Modalities 13
YM BioSciences Inc. Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
YM BioSciences Inc. – Drug Profiles 16
Biomab EGFR 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Cisplatin + Vinorelbine + Nimotuzumab 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CYT-997 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
CYT387 20
Product Description 20
Mechanism of Action 20
3. R&D Progress 20
Nimotuzumab + Cisplatin 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Nimotuzumab + Docetaxel + Carboplatin 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Nimotuzumab + Gemcitabine 24
Product Description 24
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
MacroGenics, Inc. – Product Pipeline Review – 2012
TopoTarget A/S – Product Pipeline Review – 2012
YM BioSciences Inc. – Product Pipeline Review – 2012
ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012
Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012
4. Acucela Inc. – Product Pipeline Review – 2012
Aldagen, Inc. – Product Pipeline Review – 2012
Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012
DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com